News

Patients in this cohort were nucleoside naive e-antigen (HBeAg)-positive patients with chronic hepatitis B infection. HBeAg is a viral protein identified as a marker of active replication of

The decision follows advice Adventrx received from the data safety monitoring board (DSMB), and comprehensive analysis of the recently completed Phase IIb clinical trial of CoFactor for the

At closing, Chelsea will issue approximately 7.4 million shares of its common stock at $6.62, which was the closing price on November 1, 2007. The financing is expected

The Food and Drug Administration (FDA) had previously reviewed Phase I through III clinical data involving gepirone extended release (ER). In June 2004, the FDA requested an additional

The investors have agreed to purchase the shares of common stock and warrants to purchase common stock at a negotiated purchase price of $2.845 per unit, each unit

The Repeat (REtreatment with PEgasys in pATients not responding to Peg-Intron therapy) study was designed to explore whether intensified treatment with a higher fixed-dose induction of Pegasys in

Patients in the study treated with a Simcor combination containing 20mg simvastatin had significantly better reductions in non-HDL (total cholesterol minus HDL) cholesterol compared to 20mg simvastatin therapy

Barr has filed its abbreviated new drug application (ANDA) containing a paragraph IV certification for a generic Ritalin LA product with the Food & Drug Administration in May

The patent claims are based on a significant body of data supporting the use of thymosin beta 4 for wound healing of the cornea and other areas in